Acyl bromides
eMolecules Oakwood Chemicals Copper(II) bromide 2 5kg 480169542 BR1147 0 000 7789-45-9 MFCD00010970 223 354 Br2Cu
Oakwood Chemicals Copper(II) bromide 2 5kg 480169542 BR1147 0 000 7789-45-9 MFCD00010970 223 354 Br2Cu
Medchemexpress LLC Clidinium bromide | 3485-62-9 | 99.0% | 1 ML
Clidinium bromide is a quaternary amine antimuscarinic agent. It may help alleviate symptoms of cramping and abdominal/stomach pain by decreasing stomach acid and slowing the intestines in vivo. It is for research use only and not sold to patients.
- Quaternary amine antimuscarinic agent
- May decrease stomach acid
- May slow intestines in vivo
- Helps with cramping and abdominal/stomach pain symptoms
Medchemexpress LLC Aclidinium (Bromide) | 320345-99-1 | C26H30BrNO4S2 | 100 MG
Aclidinium (Bromide) | 320345-99-1 | C26H30BrNO4S2 | 100 MG
Medchemexpress LLC Azido-choline bromide | 2059973-54-3 | 99.6% | 239.11 g·mol⁻¹ | C6H15BrN4O | 1 ML
N3-Cho bromide (azido-choline bromide) is an azide-bearing choline analogue supplied as a ready-to-use 10 mM solution in DMSO for bioorthogonal labeling and click chemistry applications. It is intended for incorporation into membrane mimetics and for use in azide-alkyne cycloaddition workflows.
- Contains an azide functional group compatible with click chemistry reactions.
- Supplied as a 10 mM solution in DMSO, ready for dilution or reaction.
- High purity (listed at 99.63%), suitable for research use.
- Soluble in DMSO and water.
- Stable in solution when sealed at -80°C (up to 6 months) or -20°C (up to 1 month).
- Useful for membrane labeling and synthesis of phospholipid head-group analogues.
Medchemexpress LLC Thonzonium bromide | 553-08-2 | 99.86% | 1 ML
Thonzonium bromide is an antibacterial agent and monocationic surface-active agent that inhibits RANKL-induced osteoclast formation and bone resorption in vitro. It prevents LPS-induced bone loss in vivo by blocking RANKL-induced activation of NF-κB, ERK, c-Fos, and NFATc1, which are crucial for osteoclast formation. Additionally, it disrupts F-actin ring formation in mature osteoclasts and inhibits proton transport in a dose-dependent manner.
- Inhibits RANKL-induced osteoclast formation
- Prevents LPS-induced bone loss in vivo
- Blocks key signaling pathways for osteoclast formation
- Disrupts F-actin ring formation in mature osteoclasts
- Inhibits proton transport
Medchemexpress LLC Tiotropium bromide monohydrate | 411207-31-3 | 99.7% | 100 MG
Tiotropium bromide (BA-679 BR) monohydrate is a long-acting muscarinic receptor antagonist. It is for research use only.
- Long-acting muscarinic receptor antagonist.
![Medchemexpress LLC 1-Hexadecanaminium, N-[2-[[(4-methoxyphenyl)methyl]-2-pyrimidinylamino]ethyl]-N,N-dimethyl-, bromide (1:1) | 553-08-2 | 99.9% | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000412988-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 1-Hexadecanaminium, N-[2-[[(4-methoxyphenyl)methyl]-2-pyrimidinylamino]ethyl]-N,N-dimethyl-, bromide (1:1) | 553-08-2 | 99.9% | 100 MG
Thonzonium bromide is an antibacterial agent and a monocationic surface-active agent. It inhibits RANKL-induced osteoclast formation and bone resorption in vitro, and prevents LPS-induced bone loss in vivo. This compound also inhibits proton transport in a dose-dependent manner (EC50=69 μM).
- Antibacterial agent.
- Monocationic surface-active agent.
- Inhibits RANKL-induced osteoclast formation and bone resorption in vitro.
- Prevents LPS-induced bone loss in vivo.
- Inhibits proton transport in a dose-dependent manner (EC50=69 μM).
- Blocks RANKL-induced activation of NF-κB, ERK, and c-Fos, as well as NFATc1 induction.
- Disrupts F-actin ring formation, causing disturbances in cytoskeletal structure in mature osteoclasts during bone resorption.
- Exhibits protective effects in an in vivo murine model of LPS-induced calvarial osteolysis.
Medchemexpress LLC QX-314 (bromide) | 24003-58-5 | MFCD00083182 | 96.6% | 343.30 | C16H27BrN2O | 1 ML
QX-314 bromide is a membrane-impermeable, permanently charged sodium channel blocker provided as a ready-to-use 10 mM solution in DMSO or as a solid for reconstitution. It is commonly used in electrophysiology and neurophysiology experiments to selectively block intracellular voltage-gated sodium channels during recordings and manipulations.
- Membrane-impermeable quaternary lidocaine derivative.
- Available as 10 mM solution in DMSO or solid for reconstitution.
- Used to block intracellular voltage-gated sodium channels in electrophysiology.
- CAS number 24003-58-5 for unambiguous identification.
- Supplied with reported purity suitable for research applications.
Medchemexpress LLC N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine | 67219-55-0 | 98.9% | 633.69 | 5 G
N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine, also known as 5'-O-DMT-N4-Bz-dC, is a compound that can be used for the synthesis of oligodeoxynucleotides containing a 3'-S-phosphorothiolate (3'-PS) linkage. It serves as a useful tool for probing enzyme-catalyzed cleavage processes in DNA.
- Used for synthesis of oligodeoxynucleotides.
- Useful tool for probing enzyme-catalyzed cleavage processes in DNA.
Medchemexpress LLC Rapacuronium bromide (Org 9487) | 156137-99-4 | 98.0% | 677.80 | 25 MG
Rapacuronium bromide (Org 9487) is a non-depolarizing neuromuscular blocker and an allosteric modulator of muscarinic acetylcholine receptor (mAChR). It is for research use only and not sold to patients.
- Non-depolarizing neuromuscular blocker
- Allosteric modulator of muscarinic acetylcholine receptor (mAChR)
Medchemexpress LLC Vecuronium bromide | 50700-72-6 | MFCD00867762 | 99.9% | 100 MG
Vecuronium bromide is a non-depolarizing neuromuscular blocking agent. It also functions as a nicotinic acetylcholine receptor (nAChR) inhibitor and a muscle relaxant. This compound can be used for pre-surgical anesthesia and is intended for research use only.
- Non-depolarizing neuromuscular blocking agent
- Inhibits nicotinic acetylcholine receptors (nAChR)
- Acts as a muscle relaxant
- Can be used for pre-surgical anesthesia
- Suitable for research applications only
Medchemexpress LLC 1,3,5-Tri-o-benzoyl-a-d-ribofuranose | 22224-41-5 | 99.75% | 462.45 | 1 ML
1,3,5-Tri-O-benzoyl-a-D-ribofuranose is a purine nucleoside analog, which exhibits broad antitumor activity by targeting indolent lymphoid malignancies. Its anticancer mechanisms involve inhibiting DNA synthesis and inducing apoptosis.
- Purine nucleoside analog
- Broad antitumor activity
- Targets indolent lymphoid malignancies
- Inhibits DNA synthesis
- Induces apoptosis